These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 17453392
1. A novel rat model for the study of deficits in bone formation in type-2 diabetes. Liu Z, Aronson J, Wahl EC, Liu L, Perrien DS, Kern PA, Fowlkes JL, Thrailkill KM, Bunn RC, Cockrell GE, Skinner RA, Lumpkin CK. Acta Orthop; 2007 Feb; 78(1):46-55. PubMed ID: 17453392 [Abstract] [Full Text] [Related]
4. Bone regeneration and fracture healing. Experience with distraction osteogenesis model. Richards M, Goulet JA, Weiss JA, Waanders NA, Schaffler MB, Goldstein SA. Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S191-204. PubMed ID: 9917639 [Abstract] [Full Text] [Related]
5. Altered bone mass, geometry and mechanical properties during the development and progression of type 2 diabetes in the Zucker diabetic fatty rat. Prisby RD, Swift JM, Bloomfield SA, Hogan HA, Delp MD. J Endocrinol; 2008 Dec; 199(3):379-88. PubMed ID: 18755885 [Abstract] [Full Text] [Related]
7. Increased aldosterone levels in a model of type 2 diabetes mellitus. Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J. Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873 [Abstract] [Full Text] [Related]
8. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Jöhren O, Dendorfer A, Dominiak P, Raasch W. Brain Res; 2007 Dec 12; 1184():160-7. PubMed ID: 17945204 [Abstract] [Full Text] [Related]
9. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis. Haque T, Hamade F, Alam N, Kotsiopriftis M, Lauzier D, St-Arnaud R, Hamdy RC. Bone; 2008 Jun 12; 42(6):1144-53. PubMed ID: 18372226 [Abstract] [Full Text] [Related]
12. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. Follak N, Klöting I, Wolf E, Merk H. Bone; 2004 Jul 12; 35(1):144-52. PubMed ID: 15207750 [Abstract] [Full Text] [Related]
14. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Belin de Chantemèle EJ, Vessières E, Guihot AL, Toutain B, Maquignau M, Loufrani L, Henrion D. Cardiovasc Res; 2009 Mar 01; 81(4):788-96. PubMed ID: 19050009 [Abstract] [Full Text] [Related]
17. Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. Hamann C, Rauner M, Höhna Y, Bernhardt R, Mettelsiefen J, Goettsch C, Günther KP, Stolina M, Han CY, Asuncion FJ, Ominsky MS, Hofbauer LC. J Bone Miner Res; 2013 Mar 01; 28(3):627-38. PubMed ID: 23109114 [Abstract] [Full Text] [Related]
18. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. Pereira M, Gohin S, Lund N, Hvid A, Smitham PJ, Oddy MJ, Reichert I, Farlay D, Roux JP, Cleasby ME, Chenu C. Osteoporos Int; 2017 Jan 01; 28(1):309-320. PubMed ID: 27468901 [Abstract] [Full Text] [Related]